Biologist/Molecular Pathologist (M/F)

DESCRIPTION: IHU RespirERA is looking for a qualified practitioner biologist/molecular pathologist to join its specialized molecular biology team. The successful candidate will work closely with multidisciplinary physicians and experts, using state-of-the-art technologies. The position offers exceptional prospects for growth and development in a supportive, team-oriented and stimulating environment. The Molecular Pathology Laboratory has an average annual activity of 1,200 cases, including tissue and liquid biopsies. The laboratory's technical platform is complete and up-to-date (multi-panel NGS, PCR, FISH). The molecular biology activity is COFRAC ISO 15189 accredited.

The laboratory has been selected as a National Referral Lab for “Lung Genetics” and a National and International Reference Center for liquid biopsies. MAIN RESPONSIBILITIES: Diagnostic activity in molecular biology with a focus on thoracic pathology. Responsible for clinical validation of molecular testing in tissues and biofluids. Actively participate in biobanking activities and analytical validations (ISO 15 189). Set up a common clinico-molecular and pathological database (including exposome and lung microbiome datasets). Work closely with INRIA partners to develop AI algorithms for diagnosis and prediction of response to personalized treatment. Actively participate in translational research projects.

Promote effective relationships within the department. Support and participate in presentations at national scientific meetings and preparation of publications for submission to peer-reviewed journals. Teaching responsibilities extend to medical students, pathology interns and PhD students. PROFILE: Doctor of Medicine (MD or MD/PhD) with relevant certifications and experience in molecular biology. The job offer will be based on the candidate's skills, previous relevant experience, applicable degrees/certifications, as well as internal equity and market data. Monthly salary is discussed based on CV and degree of expertise. An IHU bonus may be applicable. Contractual recruitment. Position available immediately.

APPLICATIONS MUST INCLUDE: Letter of motivationCurriculum VitaeList of publications, top ten in the applicant's opinion, summary of research a,d teaching activitiesAt least on letter of recommendationCONTACT: Pr Paul HOFMAN, IHU RespirERA Director: hofman. p@chu-nice. frWHO WE ARE?Established in Nice in 2023 by the President of France, IHU RespirERA is a pioneering French institute on an international scale, with a mission to revolutionize the field of respiratory diseases associated with age and the environment.

By applying innovative modeling techniques, IHU RespirERA aims to transform the diagnosis, treatment and prevention of respiratory diseases by taking into account the impact of the environment on patients. This visionary approach seeks to replace the traditional one-size-fits-all approach with personalized or precision medicine for the management of chronic respiratory diseases and lung cancer. IHU RespirERA strives to provide accurate diagnoses and treatments tailored to each patient's unique biological and environmental characteristics. To achieve this goal, IHU RespirERA carries out in-depth analyses of multi-omics health data and develops targeted therapies.

By bringing together a diverse team of experts and using multi-omics methodologies, IHU RespirERA is paving the way for a revolutionary, comprehensive approach to personalized medicine in prevention and care. The center also prioritizes the dissemination of knowledge, offering training courses for students, healthcare professionals, industrial partners and even patients themselves. Thanks to this collaborative effort, expertise and advances in personalized respiratory medicine are widely shared and applied, ultimately translating into improved patient outcomes. IHU RespirERA represents:

An alliance of national and international teams of experts in thoracic pathologyA unique hub for future innovative medical advancesPromoting interdisciplinary collaboration between academia, industry, research, education and healthcareA technological and translational platform dedicated exclusively to the study of the lung and its ecosystemCommitted to serving patients, researchers and the general publicProviding training opportunities for students, healthcare professionals, industrial partners and patientsConducting innovative research and providing cutting-edge care for lung diseasesHarnessing the potential of personalized medicine (6P) to revolutionize the treatment of lung diseasesStrengthening the international appeal of the PACA region.